SK
Susanth Kumar Satapathy
About Susanth Kumar Satapathy
Data last updated:
Susanth Kumar Satapathy is a Director at Biswa Pharmaceuticals Private Limited (since 2018), Partner at Reluxe Developers Llp (since 2025) and Partner at Lux Nest Developers Llp (since 2025). The companies operate in Electrnoics. The largest current company by reported revenue is Biswa Pharmaceuticals Private Limited at ₹18.36 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Aug 2018 | 2018 | ₹18.36 Cr (FY 2024) | Active | |
| Partner | 05 Dec 2025 | 2025 | Active | ||
| Partner | 28 Nov 2025 | 2025 | Active |
Board colleagues of Susanth Kumar Satapathy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pavan Kumar Ambati | 07592323 | Biswa Pharmaceuticals Private Limited , Reluxe Developers Llp and 1 more | Director |
| Ratikanta Panigrahi | 07592344 | Biswa Pharmaceuticals Private Limited | Director |
| Pavan Bharath Saragadam | 08616102 | Reluxe Developers Llp , Lux Nest Developers Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Susanth Kumar Satapathy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Susanth Kumar Satapathy
Susanth Kumar Satapathy currently holds 3 directorships: Biswa Pharmaceuticals Private Limited (Director, since 02 Aug 2018, revenue ₹18.36 Cr (FY 2024)); Reluxe Developers Llp (Partner, since 05 Dec 2025); Lux Nest Developers Llp (Partner, since 28 Nov 2025).
Susanth Kumar Satapathy was first appointed on 02 Aug 2018 as Director at Biswa Pharmaceuticals Private Limited. The most recent appointment on record is 05 Dec 2025 at Reluxe Developers Llp.
The current boards of Susanth Kumar Satapathy's companies include Pavan Kumar Ambati (Biswa Pharmaceuticals Private Limited), Ratikanta Panigrahi (Biswa Pharmaceuticals Private Limited), Pavan Bharath Saragadam (Reluxe Developers Llp).